The impact of biosensing in a pandemic outbreak: COVID-19
- PMID: 32421627
- PMCID: PMC7202811
- DOI: 10.1016/j.bios.2020.112274
The impact of biosensing in a pandemic outbreak: COVID-19
Abstract
COVID-19 pandemic outbreak is the most astounding scene ever experienced in the XXI century. In this opinionated review, we underscore the crucial role of biosensing to handle with such situations. As a matter of fact, testing accelerates life-saving decisions on treatment and isolation of COVID-19 patients in an early stage, and thereby, decelerating or even preventing the spread of such emerging infectious diseases. Meanwhile, it is also proven that a timely and broad application of testing leads to lower mortality rates in countries like Germany or South Korea. Besides, biosensors are also powerful tools for effective assessment of clinical progress and to provide alertness on severity or critical trends of infection. In view hereof, we critically discuss the state-of-the-art biosensing devices for COVID-19 testing. We spot the urgent needs and highlight innovative diagnostic approaches for targeting various COVID-19 related biomarkers. Finally, we outline our recommendations on biosensors and biosensing-related issues towards pandemic outbreaks.
Keywords: Biosensors; CRISPR; Emerging infectious diseases; Lateral flow assays; On-site testing; PCR; Serological tests.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes - Mar 27. Abbott MediaRoom; 2020. https://abbott.mediaroom.com/2020-03-27-Abbott-Launches-Molecular-Point-... 2020 [WWW Document] (accessed 3.28.20)
-
- An J., Liao X., Xiao T., Qian S., Yuan J., Ye H., Qi F., Shen C., Liu Yang, Wang L., Cheng X., Li N., Cai Q., Wang F., Chen J., Liu Yingxia, Wang Y., Zhang F., Fu Y., Tan X., Liu L., Zhang Z. medRxiv; 2020. Clinical Characteristics of the Recovered COVID-19 Patients with Re-detectable Positive RNA Test. 2020.03.26.20044222. - DOI - PMC - PubMed
-
- Apuzzo M., Gebrekidan S. The New York Times; 2020. Can’t Get Tested? Maybe You’re in the Wrong Country.https://www.nytimes.com/2020/03/20/world/europe/coronavirus-testing-worl... (accessed 3.20.20)
-
- Becker A. DW; 2020. Coronavirus: Rush to Develop Rapid Tests.https://www.dw.com/en/coronavirus-rush-to-develop-rapid-tests/a-52945588 (accessed 3.29.20)
-
- Bienkov A. Germany Could Issue Thousands of People Coronavirus “Immunity Certificates” So They Can Leave the Lockdown Early. https://www.businessinsider.sg/coronavirus-germany-covid-19-immunity-cer... n.d, Business Insider - Business Insider Singapore [WWW Document]. URL. (accessed 3.30.2020)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
